top of page

News
November 2018
Synendos selected for Innosuisse initial start-up program
September 2019
Synendos Therapeutics was selected for BaseLaunch Phase I (CHF 10'000)
September 2016
Andrea Chicca (University of Bern) won an Innosuisse feasibility grant and was awarded with CHF 230’000
bottom of page